BRIGHT MINDS BIOSCIENCES INC

$DRUG
Smart money positioned

6 of the Top-200 alpha managers hold $DRUG as of the latest 13F snapshot.

13F holders
92
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

6 holders · Q1 2026

$DRUG is held by 6 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 1.00%, with an average of 0.33% of portfolio. Largest holder: Vestal Point Capital, LP at 1.00%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 92 · Source: 13F-HR
01
Janus Henderson Group PLC
0.10% of portfolio
1,284,324 sh
02
Thomas H Lee Partners LP
0.05% of portfolio
1,284,324 sh
03
Mint Tower Capital Management B.V.
3.39% of portfolio
557,172 sh
04
Vivo Capital, LLC
3.38% of portfolio
557,172 sh
05
Meixler Investment Management, Ltd.
1.31% of portfolio
539,708 sh
06
Partners Value Investments L.P.
0.06% of portfolio
495,743 sh
07
Main Street Group, LTD
1.00% of portfolio
492,319 sh
08
Wellington Management Group LLP
0.23% of portfolio
432,515 sh
09
Siemens Pension Trust E V
0.03% of portfolio
297,158 sh
10
Geneva Capital Management LLC
0.24% of portfolio
283,000 sh
See all 92 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $DRUG in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $DRUG in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 09:47 UTC.